GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt,Andrew D Oxman,Gunn Elisabeth Vist,Regina Kunz,Yngve Falck-Ytter,Pablo Alonso-Coello,Holger J. Schünemann +6 more
Reads0
Chats0
TLDR
The advantages of the GRADE system are explored, which is increasingly being adopted by organisations worldwide and which is often praised for its high level of consistency.Abstract:
Guidelines are inconsistent in how they rate the quality of evidence and the strength of recommendations. This article explores the advantages of the GRADE system, which is increasingly being adopted by organisations worldwideread more
Citations
More filters
Journal ArticleDOI
Executive Summary: Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America
Stanford T. Shulman,Alan L. Bisno,Herbert W. Clegg,Michael A. Gerber,Edward L. Kaplan,Grace M. Lee,Judith M. Martin,Chris A. Van Beneden +7 more
TL;DR: The guideline updates the 2002 Infectious Diseases Society of America guideline and discusses diagnosis and management, and recommendations are provided regarding antibiotic choices and dosing.
Journal ArticleDOI
Early Intervention for Children With Autism Spectrum Disorder Under 3 Years of Age: Recommendations for Practice and Research
Lonnie Zwaigenbaum,Margaret L. Bauman,Roula Choueiri,Connie Kasari,Alice S. Carter,Doreen Granpeesheh,Zoe Mailloux,Susanne Smith Roley,Sheldon L. Wagner,Deborah Fein,Karen Pierce,Timothy Buie,Patricia A. Davis,Craig J. Newschaffer,Diana L. Robins,Amy M. Wetherby,Wendy L. Stone,Nurit Yirmiya,Annette Estes,Robin L Hansen,James C. McPartland,Marvin R. Natowicz +21 more
TL;DR: This article reviews current evidence for autism spectrum disorder interventions for children aged <3 years, based on peer-reviewed articles published up to December 2013 and identifies several comprehensive and targeted treatment models with evidence of clear benefits.
Journal ArticleDOI
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis
TL;DR: 5-ASA was significantly superior to placebo with regard to all measured outcome variables and the failure to induce global/clinical remission, global/ clinical improvement, endoscopic remission, adherence, adverse events, withdrawals due to adverse events and withdrawals or exclusions after entry were found.
Journal ArticleDOI
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).
Joep Perk,Guy De Backer,Helmut Gohlke,Ian D. Graham,Željko Reiner,W. M. Monique Verschuren,Christian Albus,Pascale Benlian,Gudrun Boysen,Renata Cifkova,Christi Deaton,Shah Ebrahim,Miles Fisher,Giuseppe Germanò,Richard J. Hobbs,Arno W. Hoes,Sehnaz Karadeniz,Alessandro Mezzani,Eva Prescott,Lars Rydén,Martin Scherer,M Syvänne,Wilma J.M. Scholte op Reimer,Christiaan J. Vrints,David R. Wood,José Luis Zamorano,Faiez Zannad +26 more
TL;DR: The European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) as discussed by the authors were developed by the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).
Journal ArticleDOI
Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive
Roman Jaeschke,Gordon H. Guyatt,Phil Dellinger,Holger J. Schünemann,Mitchell M. Levy,Regina Kunz,Susan L Norris,Julian Bion +7 more
TL;DR: In this article, Roman Jaeschke and colleagues describe a simple technique for clarifying opinion in a guideline committee, which can make consensus difficult in large and diverse guideline committees.
References
More filters
Journal ArticleDOI
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
Jacques E. Rossouw,Garnet L. Anderson,Ross L. Prentice,Andrea Z. LaCroix,Charles Kooperberg,Marcia L. Stefanick,Rebecca D. Jackson,Shirley A.A. Beresford,Barbara V. Howard,Karen C. Johnson,Jane Morley Kotchen,Judith K. Ockene +11 more
TL;DR: Overall health risks exceeded benefits from use of combined estrogen plus progestin for an average 5.2-year follow-up among healthy postmenopausal US women, and the results indicate that this regimen should not be initiated or continued for primary prevention of CHD.
Journal ArticleDOI
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
Stephen B. Hulley,Deborah Grady,Trudy L. Bush,Curt D Furberg,David M. Herrington,Betty Riggs,Eric Vittinghoff +6 more
TL;DR: Treatment with oral conjugated equine estrogen plus medroxyprogesterone acetate did not reduce the overall rate of CHD events in postmenopausal women with established coronary disease and the treatment did increase the rate of thromboembolic events and gallbladder disease.
Journal ArticleDOI
Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.
Echt Ds,Philip R. Liebson,Mitchell Lb,Robert W. Peters,Obias-Manno D,Barker Ah,Arensberg D,Baker A,Lawrence S. Friedman,Greene Hl +9 more
TL;DR: There was an excess of deathsDue to arrhythmia and deaths due to shock after acute recurrent myocardial infarction in patients treated with encainide or flecainide.
Journal ArticleDOI
A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction.
TL;DR: Finding and analyzing all therapeutic trials in a given field has become such a difficult and specialized task that the clinical experts called on to summarize the evidence in a timely fashion need access to better databases and new statistical techniques to assist them.
Journal ArticleDOI
Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group.
David Atkins,Martin P Eccles,Signe Flottorp,Gordon H. Guyatt,David Henry,Suzanne Hill,Alessandro Liberati,Dianne L. O'Connell,Andrew D Oxman,Bob Phillips,Holger J. Schünemann,Holger J. Schünemann,Tessa Tan-Torres Edejer,Gunn Elisabeth Vist,John W Williams +14 more
TL;DR: The objective was to critically appraise six prominent systems for grading levels of evidence and the strength of recommendations as a basis for agreeing on characteristics of a common, sensible approach.